Clinical Trial Update: Comparison of Bimatoprost and Latanoprost in Patients With Chronic Angle-Closure Glaucoma: A Randomized Cross-Over Study [NA]

View source ↗

Summary

A randomized cross-over study comparing bimatoprost and latanoprost in patients with chronic angle-closure glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angle-closure Glaucoma

Drugs mentioned

• Lumigan (bimatoprost)
• Xalatan (latanoprost)

Snippet

Sponsor: Singapore National Eye Centre | Conditions: Glaucoma, Angle-Closure | NA | Status: UNKNOWN